A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer

NCT00144066 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: platinum-based chemotherapy alone (up to six cycles)
DRUG: platinum-based chemotherapy followed by maintenance therapy with gefitinib

Sponsor

West Japan Thoracic Oncology Group